Comparing Ciprofloxacin Ophthalmic vs Dexamethasone / Neomycin / Polymyxin B Ophthalmic
Ciprofloxacin ophthalmic | Dexamethasone / neomycin / polymyxin b ophthalmic |
|
---|
Ciprofloxacin ophthalmic | Dexamethasone / neomycin / polymyxin b ophthalmic |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Conjunctivitis - Bacterial, Corneal Ulcer, Ophthalmic Surgery. ciprofloxacin ophthalmic may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Blepharitis, Conjunctivitis - Bacterial, Uveitis, Keratitis, Keratoconjunctivitis. dexamethasone / neomycin / polymyxin b ophthalmic may also be used for purposes not listed in this... View more |
Related suggestions Conjunctivitis, Bacterial
|
|||||||||||||||
More about Ciprofloxacin ophthalmic | More about Dexamethasone / neomycin / polymyxin b ophthalmic | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Ciprofloxacin ophthalmic has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Dexamethasone / neomycin / polymyxin b ophthalmic has an average rating of 7.8 out of 10 from a total of 13 ratings on Drugs.com. 73% of reviewers reported a positive effect, while 18% reported a negative effect. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
See also: ciprofloxacin ophthalmic side effects in more detail. |
See also: dexamethasone / neomycin / polymyxin b ophthalmic side effects in more detail. |
||||||||||||||||
Generic Availability | |||||||||||||||||
Lower cost generic |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all ciprofloxacin ophthalmic prices |
View all dexamethasone / neomycin / polymyxin b ophthalmic prices |
||||||||||||||||
Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Ciloxan | AK-Trol, Dexacine, Dexasporin, Maxitrol, Neo-Poly-Dex, NPD Ophthalmic Ointment, Poly-Dex | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 88 drugs are known to interact with dexamethasone / neomycin / polymyxin b ophthalmic:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||
First Approval Date | |||||||||||||||||
March 30, 1998 |
July 19, 1963 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
|||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.